Host Chris Miglino interviews CEO Paul Romness. He talks about the company going public, finishing their clinical trial and FDA approval.
December 5, 2025
December 3, 2025
November 26, 2025
November 18, 2025
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.